Italy In Vitro Diagnostics Market (2023 - 2030) Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application (Infectious Disease, Diabetes, Oncology/Cancer), By End-use, And Segment Forecasts

Market Segmentation

• Italy In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Instruments
  • Reagents
  • Services
• Italy In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Immunoassay
    • By Product
      • Instruments
      • Reagents
      • Services
    • By Technology
      • Radioimmunoassay (RIA)
      • Enzyme Immunoassays (EIA)/ELISA
        • Chemiluminescence Immunoassays (CLIA)
        • Fluorescence Immunoassays (FIA)
      • Rapid Test
      • Others
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics/Genetics
    • By Product
      • Instruments
      • Reagents
      • Services
    • By Technology
      • Instruments
      • Polymerase Chain Reaction (PCR)
      • Sequencing
      • Hybridization
      • Chips & Microarrays
      • TMA
      • INAAT
      • Mass Spectrometry
      • Others
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services
• Italy In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Infectious Disease
  • Diabetes
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Others
• Italy In Vitro Diagnostics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Core Lab, by Test Type
    • SWA (Serum Work Area)
      • Clinical Chemistry
      • Immunochemistry
    • Hematology
    • Coagulation
    • Urine Test
    • Others
  • Core Lab, by Location
    • SWA (Serum Work Area)
      • Public Hospitals
      • Large Private Hospitals
      • Private
    • Hematology
      • Public Hospitals
      • Large Private Hospitals
      • Private
    • Coagulation
      • Public Hospitals
      • Large Private Hospitals
      • Private
    • Urine Test
      • Public Hospitals
      • Large Private Hospitals
      • Private
  • Molecular Lab
    • HPV
    • Herpetics
    • Hepatitis
    • HIV
    • NIPT
    • Others
  • Pathology Lab
    • Anatomic Pathology 
      • Advanced Staining (Immunohistochemistry)
        • Public Hospitals
        • Large Private Hospitals
        • Private
      • Primary Staining (Hematoxylin Eosin and Histochemistry)
        • Public Hospitals
        • Large Private Hospitals
        • Private
    • Others
  • Blood Banks
    • SWA (Serum Work Area)
    • Molecular Test
  • Point of Care (PoC)
    • Clinics
    • Hospitals
  • Retail
    • Military Premises
    • Airports
    • Others
  • Others
    • NGS
    • Mass Spectrometry
    • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance